Page 499 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 499

CHAPTER 23  Cancer of the Gastrointestinal Tract  477


           colostomy, improved outcomes have been achieved with defini-   21.   Wallace  J, Matthiesen DT, Patnaik AK: Hemimaxillec-
           tive chemoradiation. The standard approach to therapy is con-  tomy for the treatment of oral tumors in 69 dogs, Vet Surg 21:
                                                                     337–341, 1992.
           comitant RT and chemotherapy using 5-FU and mitomycin C.
  VetBooks.ir  Surgery is reserved for locally recurrent or persistent disease. The    22.   Schwarz PD, Withrow SJ, Curtis CR, et al.: Mandibular resection
                                                                     as a treatment for oral cancer in 81 dogs, J Am Anim Hosp Assoc
           mean 5-year disease-free survival and overall survival rates are
                                                                     27:601–610, 1991.
           60% and 75%, respectively. Size and degree of invasion of the    23.   Schwarz PD, Withrow SJ, Curtis CR, et al.: Partial maxillary resec-
           primary tumor, regional LN involvement, and presence of dis-  tion as a treatment for oral cancer in 61 dogs, J Am Anim Hosp Assoc
           tant metastases are important prognostic factors. Identification of   27:617–624, 1991.
           biomarkers that may serve as predictors of outcome or targets for    24.   Sarowitz BN, Davis GJ, Kim S: Outcome and prognostic factors
           therapy is being explored.                                following curative-intent surgery for oral tumours in dogs: 234
                                                                     cases (2004 to 2014), J Small Anim Pract 58:146–153, 2017.
           References                                             25.   Bronden LB, Eriksen T, Kristensen AT: Oral malignant melano-
                                                                     mas and other head and neck neoplasms in Danish dogs: data from
                                                                     the danish veterinary cancer registry, Acta Vet Scand 51:54, 2009.
             1.   Patnaik AK, Liu SK, Hurvitz AI, et al.: Nonhematopoietic neo-   26.   Richardson  RC: Canine transmissible venereal tumor,  Compend
               plasms in cats, J Natl Cancer Inst 54:855–860, 1975.  Contin Educ Pract Vet 3:951–956, 1981.
             2.   Hoyt RF, Withrow SJ: Oral malignancy in the dog, J Am Anim    27.   Straw RC, LeCouteur RA, Powers BE, et al.: Multilobular osteo-
               Hosp Assoc 20:83–92, 1984.                            chondrosarcoma of the canine skull: 16 cases (1978-1988), J Am
             3.   Dorn CR, Priester WA: Epidemiologic analysis of oral and pha-  Vet Med Assoc 195:1764–1769, 1989.
               ryngeal cancer in dogs, cats, horses and cattle, J Am Vet Med Assoc    28.   Dernell WS,  Straw  RC,  Cooper  MF,  et  al.:  Multilobular  osteo-
               169:1202–1206, 1976.                                  chondrosarcoma in 39 dogs: 1979-1993, J Am Anim Hosp Assoc
             4.   Vos JH, van der Gaag I: Canine and feline oral-pharyngeal tumours,   34:11–18, 1998.
               Zentralbl Veterinarmed A 34:420–427, 1987.         29.   Farrelly J, Denman DL, Hohenhaus AE, et al.: Hypofractionated
             5.   Stebbins KE, Morse CC, Goldschmidt MH: Feline oral neoplasia:   radiation therapy of oral melanoma in five cats, Vet Radiol Ultra-
               a ten year survey, Vet Pathol 26:121–128, 1989.       sound 45:91–93, 2004.
             6.   Dorn CR, Taylor DON, Frye FL, et al.: Survey of animal neoplasms    30.   Iussich S, Maniscalco L, Di Sciuva A, et al.: PDGFRs expression in
               in Alameda and Contra Costa Counties, California. I. Methodol-  dogs affected by malignant oral melanomas: correlation with prog-
               ogy and description of cases, J Natl Cancer Inst 40:295–305, 1968.  nosis, Vet Comp Oncol 15:462–469, 2017.
             7.   Dorn  CR, Taylor  DON, Schneider R, et  al.: Survey of animal    31.   Smedley RC, Lamoureux J, Sledge DG, et al.: Immunohistochemi-
               neoplasms in Alameda and Contra Costa Counties, California. II.   cal diagnosis of canine oral amelanotic melanocytic neoplasms, Vet
               Cancer morbidity in dogs and cats from alameda county, J Natl   Pathol 48:32–40, 2011.
               Cancer Inst 40:307–318, 1968.                      32.   Harvey HJ, MacEwen GE, Braun D, et al.: Prognostic criteria for
             8.   Cohen D, Brodey RS, Chen SM: Epidemiologic aspects of oral   dogs with oral melanoma, J Am Vet Med Assoc 178:580–582, 1981.
               and pharyngeal neoplasms in the dog, Am J Vet Res 25:1776–1779,    33.   Hahn  KA, DeNicola DB, Richardson RC, et  al.: Canine oral
               1964.                                                 malignant melanoma: prognostic utility of an alternative staging
             9.   Kudnig ST, Ehrhart N, Withrow SJ, et al.: Survival analysis of oral   system, J Small Anim Pract 35:251–256, 1994.
               melanoma in dogs, Vet Cancer Soc Proc 23:39, 2003.   34.   William LE, Packer RA: Association between lymph node size and
            10.   Heyman SJ, Diefenderfer DL, Goldschmidt MH, et al.: Canine   metastasis in dogs with oral malignant melanoma: 100 cases (1987-
               axial skeletal osteosarcoma: a retrospective study of 116 cases (1986   2001), J Am Vet Med Assoc 222:1234–1236, 2003.
               to 1989), Vet Surg 21:304–310, 1992.               35.   Spangler WL, Kass PH: The histologic and epidemiologic bases
            11.   Ramos-Vara JA, Beissenherz ME, Miller MA, et al.: Retrospective   for prognostic considerations in canine melanocytic neoplasia, Vet
               study of 338 canine oral melanomas with clinical, histologic, and   Pathol 43:136–149, 2006.
               immunohistochemical review of 129 cases, Vet Pathol 37:597–608,    36.   Sánchez J, Ramirez GA, Buendia AJ, et al.: Immunohistochemi-
               2000.                                                 cal characterization and evaluation of prognostic factors in canine
            12.   Todoroff RJ, Brodey RS: Oral and pharyngeal neoplasia in the dog:   oral melanomas with osteocartilaginous differentiation, Vet Pathol
               a retrospective survey of 361 cases, J Am Vet Med Assoc 175:567–  44:676–682, 2007.
               571, 1979.                                         37.   Bergin IL, Smedley RC, Esplin DG, et al.: Prognostic evaluation of
            13.   Withrow SJ, Holmberg DL: Mandibulectomy in the treatment of   Ki67 threshold value in canine oral melanoma, Vet Pathol 48:41–
               oral cancer, J Am Anim Hosp Assoc 19:273–286, 1983.   53, 2011.
            14.   Withrow SJ, Nelson AW, Manley PA, et al.: Premaxillectomy in    38.   Newman SJ, Jankovsky JM, Rohrbach BW, et al.: C-kit expression
               the dog, J Am Anim Hosp Assoc 21:49–55, 1985.         in canine mucosal melanomas, Vet Pathol 49:760–765, 2012.
            15.   White RAS, Gorman NT, Watkins SB, et al.: The surgical manage-   39.   Smedley RC, Spangler WL, Esplin DG, et al.: Prognostic markers
               ment of bone-involved oral tumours in the dog, J Small Anim Pract   for canine melanocytic neoplasms: a comparative review of the liter-
               26:693–708, 1985.                                     ature and goals for future investigations, Vet Pathol 48:54–72, 2011.
            16.   Bradley  RL, MacEwen EG, Loar AS: Mandibular resection for    40.   Boston SE, Lu X, Culp WTN, et al.: Efficacy of systemic adjuvant
               removal of oral tumors in 30 dogs and 6 cats, J Am Vet Med Assoc   therapies administered to dogs after excision of oral malignant mel-
               184:460–463, 1984.                                    anomas: 151 cases (2001–2012), J Am Vet Med Assoc 245:401–407,
            17.   Salisbury SK, Richardson DC, Lantz GC: Partial maxillectomy and   2014.
               premaxillectomy in the treatment of oral neoplasia in the dog and    41.   Tuohy  JL, Selmic LE, Worley  DR, et  al.: Outcome following
               cat, Vet Surg 15(16), 1986.                           curative-intent surgery for oral melanoma in dogs: 70 cases (1998–
            18.   Salisbury SK, Lantz GC: Long-term results of partial mandibulec-  2011), J Am Vet Med Assoc 245:1266–1273, 2014.
               tomy for treatment of oral tumors in 30 dogs, J Am Anim Hosp    42.   Turrel  JM: Principles of radiation therapy. In Thielen GH,
               Assoc 24:285–294, 1988.                               Madewell BR, editors: Veterinary cancer medicine, ed 2, Philadel-
            19.   White RAS: Mandibulectomy and maxillectomy in the dog: long-  phia, 1987, Lea & Febiger.
               term survival in 100 cases, J Small Anim Pract 32:69–74, 1991.   43.   Théon  AP, Rodriguez C, Madewell BR: Analysis of  prognostic
            20.   Kosovsky JK, Matthiesen DT, Marretta SM, et al.: Results of par-  factors and patterns of failure in dogs with malignant oral tumors
               tial mandibulectomy for the treatment of oral tumors in 142 dogs,   treated with megavoltage irradiation, J Am Vet Med Assoc 210:778–
               Vet Surg 20:397–401, 1991.                            784, 1997.
   494   495   496   497   498   499   500   501   502   503   504